Effects of salmon calcitonin on patients with atypical (idiopathic) facial pain: A randomized controlled trial

Journal of Orofacial Pain

Volumn 10, Issue 4, 1996, Pages 306-315

  Schwartz, Gordon ^a,b   Galonski, Marilyn ^a   Gordon, Allan ^a   Shandling, Maureen ^a   Mock, David ^a   Tenenbaum, Howard C ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Atypical facial pain; Calcitonin; Randomized trial

Indexed keywords

ANALGESIC AGENT; CALCITONIN; SALCATONIN;

ADULT; AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FACE PAIN; FEMALE; HUMAN; MALE; MIDDLE AGED; NAUSEA; PAIN ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; VOMITING;

ADULT; AGED; ANALGESICS; CALCITONIN; CHRONIC DISEASE; DOUBLE-BLIND METHOD; FACIAL PAIN; FEMALE; HUMANS; MALE; MIDDLE AGED; NAUSEA; PAIN MEASUREMENT; VOMITING;

EID: 0030320855     PISSN: 10646655     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Friedman AP. Atypical facial pain. Headache 1969;9:27-30.
2. Loeser JD. Tic douloureux and atypical facial pain. Can Dent Assoc J 1985;51:917-923.
3. Reik L Jr. Atypical facial pain: A reappraisal. Headache 1985;25:30-32.
4. Solomon S, Lipton RB. Atypical facial pain: A review. Semin Neurol 1988;8:332-338.
5. Pfaffenrath V, Rath M, Pollman W, Keeser W. Atypical facial pain-application of the IHS criteria in a clinical sample. Cephalalgia 1993;13:84-88.
6. Graff-Radford SB, Solberg WK. Atypical odontalgia. J Craniomandib Disord Facial Oral Pain 1992;6:260-265.
7. Gratt BM, Sickles EA, Graff-Radford SB, Solberg WK. Electronic thermography in the diagnosis of atypical odontalgia: A pilot study. Oral Surg Oral Med Oral Pathol 1989;68:472-481.
8. Hapak L, Gordon A, Locker D, Shandling M, Mock D, Tenenbaum HC. Differentiation between musculoligamentous, dentoalveolar, and neurologically based craniofacial pain with a diagnostic questionnaire. J Orofacial Pain 1994;8:357-368.
9. Lascelles RG. Atypical facial pain and depression. Br J Psychiatry 1966;112:651-659.
10. Remick RA, Blasberg B, Barton JS, Campos PE, Miles JE. Ineffective dental and surgical treatment associated with atypical facial pain. Oral Surg Oral Med Oral Pathol 1983; 55:355-358.
11. Marbach JJ. Is phantom tooth pain a deafferentation (neuropathic) syndrome? Part I. Oral Surg Oral Med Oral Pathol 1993;75:95-105.
12. Drummond PD. Vascular changes in atypical facial pain. Headache 1988;28:121-123.
13. Bennet GJ. Animal models of neuropathic pain. In: Gebhart GE, Hammond DL, Jensen TS (eds). Proceedings of the Seventh World Congress on Pain: Progress in Pain Research and Management. Seattle: IASP Press, 1993:495-510.
14. Fiddler DS, Hindman JB. Intravenous calcitonin alleviates spinal anesthesia-induced phantom limb pain. Anesthesiology 1991;74:187-189.
15. Jaeger H, Maier C. Calcitonin in phantom limb pain: A double-blind study. Pain 1992;48:21-27.
16. Deftos LJ. Calcitonin. In: Flavus MJ (ed). Primer on Metabolic Bone Disease and Disorders of Mineral Metabolism, ed 2. New York: Raven Press, 1993:76-80.
17. Lyritis GP, Tsakalakos N, Magiasis B, Karachalios T, Yiatzides A, Tsekoura M. Analgesic effect of salmon calcitonin in osteoporotic vertebral fractures: A double-blind placebo-controlled clinical study. Calcif Tissue Int 1991; 49:369-372.
18. Gennari C, Agnusdei D. Calciotropic hormones and pain. Contrib Nephrol 1991;91:86-94.
19. Galli G, Gordon A, Shandling M, Mock D, Tenenbaum HC. Diagnostic and prognostic features of atypical facial pain: A pilot study [abstract]. J Orofacial Pain 1993;7:116.
20. Grunstein HS, Clifton-Bligh P, Posen S. Paget's disease of bone: Experiences with 100 patients treated with salmon calcitonin. Med J Aust 1981;2:278-280.
21. Gennari C, Agnusdei D, Camporeale A. Use of calcitonin in the treatment of bone pain associated with osteoporosis. Calcif Tissue Int 1991;49(suppl):S9-S13.
22. Singer FR. Clinical efficacy of salmon calcitonin in Paget's disease of bone. Calcif Tissue Int 1991;49(suppl):S7-S8.
23. Rifat SF, Kiningham RB, Peggs JF. Calcitonin in the treatment of osteoporotic bone pain. J Fam Pract 1992;35: 93-96.
24. Schwartz D, Flamant R, Lellouch J. Clinical Trials. London: Academic Press, 1980.
25. Kreisberg MK. Tricyclic antidepressants: Analgesic effect and indications in orofacial pain. J Craniomandib Disord Facial Oral Pain 1988;2:171-177.
26. Max MB, Kishore-Kumar R, Schafer SC, Meister B, Gracely RH, Smoller B, Dubner R. Efficacy of desipramine in painful diabetic neuropathy: A placebo-controlled trial. Pain 1991;45:3-9.
27. Tolino A, Romano L, Ronsini S, Riccio S, Montemagno U. Treatment of postmenopausal osteoporosis with salmon calcitonin nasal spray: Evaluation by bone mineral content and biochemical patterns. Int J Clin Pharmacol Ther Toxicol 1993;31:358-360.
28. Pontiroli AE, Pajetta E, Calderara A, Alberetto M, Pozza G, Manganelli V, et al. Intranasal and intramuscular human calcitonin in female osteoporosis and in Paget's disease of bone: A pilot study. J Endocrinol Invest 1991; 14:47-51.
29. Pecile A. Calcitonin and relief of pain. Bone Miner 1992; 16:187-189.
30. Szánto J, Ady N, Jozsef S. Pain killing with calcitonin nasal spray in patients with malignant tumors. Oncology 1992;49:180-182.
31. Wallach S. The role of calcitonin treatment in postmenopausal osteoporosis. Orthop Rev 1992;21:1130-1131.
32. Laurian L, Oberman Z, Graf E, Gilad S, Hoerer E, Simantov R. Calcitonin induced increase in ACTH,. β-endorphin and cortisol secretion. Horm Metab Res 1986;18:268-271.
33. Üstdal M, Dogan P, Soyuer A, Terzi S. Treatment of migraine with salmon calcitonin: Effects on plasma β-endorphin, ACTH, and cortisol levels. Biomed Pharmacother 1989;43:687-691.
34. Franceschini R, Cataldi A, Cianciosi P, Garibaldi A, Corsini G, Barreca T, Rolandi E. Calcitonin and β-endorphin secretion. Biomed Pharmacother 1993;47:305-309.
35. Candeletti S, Ferri S. Antinociceptive profile of intracereboventricular salmon calcitonin and calcitonin gene-related peptide in the mouse formalin test. Neuropeptides 1990; 17:93-98.
36. Guidobono F, Netti C, Pagani F, Sibilia V, Pecile A, Candelleti S, Ferri S. Relationship of analgesia induced by centrally injected calcitonin to the CNS serotonergic system. Neuropeptides 1986;8:259-271.
37. Olgiati VR, Guidobono F, Netti C, Pecile A. Localization of calcitonin binding sites in rat central nervous system: Evidence of its neuroactivity. Brain Res 1983;265:209-215.
38. Gennari C, Passeri M, Chierichetti SM, Piolini M. Side effects of synthetic salmon and human calcitonin. Lancet 1983;1(8324):594-595.
39. Carrozzo M, Cantatore FP, D'Amore M, Pipitone V. Side effects of calcitonin therapy. Clin Trials J 1988;25:87-88.
40. Massoth DL, Dworkin SF, LeResche L, Harrison RH, Whitney CW, Wilson L, et al. Non-specific physical symptom scores and temporomandibular disorders [abstract 1690]. J Dent Res 1995;74:223.